Literature DB >> 17607513

Preparation and characterization of rapamycin-loaded PLGA coating stent.

C J Pan1, J J Tang, Y J Weng, J Wang, N Huang.   

Abstract

In this study, using polylactic acid-co-glycolic acid (PLGA) with a molecular weight of 95,800 Da as drug carrier, three dose (low, moderate, high) rapamycin-eluting stents and the corresponding coating films were prepared. The pre- and post-expansion morphology of the rapamycin-eluting stent was examined by scanning electron microscopy (SEM), indicating that the coating was very smooth and uniform. The coating had the ability to withstand the compressive and tensile strains imparted without cracking from the stent during expansion process. There were many voids on stent coating surface after released for 18 days in release medium. The thermodynamics data of the stent coating film measured by differential scanning calorimetry (DSC) showed a lack of measurable solubility of rapamycin in the PLGA matrix. The release behavior of rapamycin from stent surface had a two phase release profile with a burst release period of about 2 days, followed by a sustained and slow release phase. The mass loss behavior of PLGA appeared linear throughout most of the degradation period, corresponding to an approximately constant mass loss rate. The platelet adhesion tests showed that the rapamycin-eluting films may have a good blood compatibility compared with control samples. Take into these results account, this novel rapamycin-eluting may be a good candidate to resolve in-stent restenosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17607513     DOI: 10.1007/s10856-007-3075-9

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  21 in total

1.  Metallic surface modification.

Authors:  I De Scheerder; E Verbeken; J Van Humbeeck
Journal:  Semin Interv Cardiol       Date:  1998 Sep-Dec

Review 2.  In-stent stenosis: pathology and implications for the development of drug eluting stents.

Authors:  Martin R Bennett
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

3.  In vitro study of release mechanisms of paclitaxel and rapamycin from drug-incorporated biodegradable stent matrices.

Authors:  Frank Alexis; Subbu S Venkatraman; Santosh Kumar Rath; Freddy Boey
Journal:  J Control Release       Date:  2004-07-23       Impact factor: 9.776

4.  Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells.

Authors:  S O Marx; T Jayaraman; L O Go; A R Marks
Journal:  Circ Res       Date:  1995-03       Impact factor: 17.367

Review 5.  Drug-eluting stents: results, promises and problems.

Authors:  Barend L van der Hoeven; Nuno M M Pires; Hazem M Warda; Pranobe V Oemrawsingh; Bart J M van Vlijmen; Paul H A Quax; Martin J Schalij; Ernst E van der Wall; J Wouter Jukema
Journal:  Int J Cardiol       Date:  2005-03-10       Impact factor: 4.164

Review 6.  Mechanisms of polymer degradation and erosion.

Authors:  A Göpferich
Journal:  Biomaterials       Date:  1996-01       Impact factor: 12.479

7.  Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle.

Authors:  R Gallo; A Padurean; T Jayaraman; S Marx; M Roque; S Adelman; J Chesebro; J Fallon; V Fuster; A Marks; J J Badimon
Journal:  Circulation       Date:  1999-04-27       Impact factor: 29.690

8.  Biocompatibility of polyurethane-coated stents: tissue and vascular aspects.

Authors:  E Rechavia; F Litvack; M C Fishbien; M Nakamura; N Eigler
Journal:  Cathet Cardiovasc Diagn       Date:  1998-10

9.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.

Authors:  Marie-Claude Morice; Patrick W Serruys; J Eduardo Sousa; Jean Fajadet; Ernesto Ban Hayashi; Marco Perin; Antonio Colombo; G Schuler; Paul Barragan; Giulio Guagliumi; Ferenc Molnàr; Robert Falotico
Journal:  N Engl J Med       Date:  2002-06-06       Impact factor: 91.245

10.  Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries.

Authors:  I K De Scheerder; K L Wilczek; E V Verbeken; J Vandorpe; P N Lan; E Schacht; H De Geest; J Piessens
Journal:  Atherosclerosis       Date:  1995-04-07       Impact factor: 5.162

View more
  12 in total

1.  S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation.

Authors:  Joseph E Aslan; Garth W Tormoen; Cassandra P Loren; Jiaqing Pang; Owen J T McCarty
Journal:  Blood       Date:  2011-07-14       Impact factor: 22.113

2.  In vitro study of dual drug-eluting stents with locally focused sirolimus and atorvastatin release.

Authors:  Svea Petersen; Janine Hussner; Thomas Reske; Niels Grabow; Volkmar Senz; Robert Begunk; Daniela Arbeiter; Heyo K Kroemer; Klaus-Peter Schmitz; Henriette E Meyer zu Schwabedissen; Katrin Sternberg
Journal:  J Mater Sci Mater Med       Date:  2013-07-12       Impact factor: 3.896

3.  Evaluation of two polymeric blends (EVA/PLA and EVA/PEG) as coating film materials for paclitaxel-eluting stent application.

Authors:  Xi Liu; Lei Lei; Jing-Wen Hou; Mu-Fei Tang; Sheng-Rong Guo; Zhong-Min Wang; Ke-Min Chen
Journal:  J Mater Sci Mater Med       Date:  2011-01-08       Impact factor: 3.896

4.  Release of PLGA-encapsulated dexamethasone from microsphere loaded porous surfaces.

Authors:  G J S Dawes; L E Fratila-Apachitei; B S Necula; I Apachitei; G J Witkamp; J Duszczyk
Journal:  J Mater Sci Mater Med       Date:  2009-08-11       Impact factor: 3.896

5.  Electrografting of a biodegradable layer as a primer adhesion coating onto a metallic stent: in vitro and in vivo evaluations.

Authors:  Gwenaelle Vergnol; Estelle Renard; Ferial Haroun; Patrice Guerin; Aymeric Seron; Christophe Bureau; Gervaise Loirand; Valerie Langlois
Journal:  J Mater Sci Mater Med       Date:  2013-08-01       Impact factor: 3.896

6.  mTOR regulates GPVI-mediated platelet activation.

Authors:  Longsheng Wang; Gang Liu; Nannan Wu; Baiyun Dai; Shuang Han; Qiaoyun Liu; Fang Huang; Zhihua Chen; Weihong Xu; Dajing Xia; Cunji Gao
Journal:  J Transl Med       Date:  2021-05-10       Impact factor: 5.531

7.  Optimization of cardiovascular stent against restenosis: factorial design-based statistical analysis of polymer coating conditions.

Authors:  Gayathri Acharya; Chi H Lee; Yugyung Lee
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

8.  Regulation of the mTOR-Rac1 axis in platelet function.

Authors:  Joseph E Aslan; Owen J T McCarty
Journal:  Small GTPases       Date:  2012 Jan-Mar

9.  Protein kinase C and P2Y12 take center stage in thrombin-mediated activation of mammalian target of rapamycin complex 1 in human platelets.

Authors:  S F Moore; R W Hunter; I Hers
Journal:  J Thromb Haemost       Date:  2014-05       Impact factor: 5.824

10.  Novel poly(L-lactide-co-ε-caprolactone) matrices obtained with the use of Zr[Acac]₄ as nontoxic initiator for long-term release of immunosuppressive drugs.

Authors:  Katarzyna Jelonek; Janusz Kasperczyk; Suming Li; Piotr Dobrzynski; Henryk Janeczek; Bozena Jarzabek
Journal:  Biomed Res Int       Date:  2013-10-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.